Open Access Open Access  Restricted Access Subscription or Fee Access

A Review on Mechanotransduction in Leiomyoma

Prashant Agarwal, Ritika Gupta


Uterine leiomyomata are the most widespread medical problem of the female reproductive tract. They are the benign tumors of uterus and clinically apparent in a large part of reproductive aged women but still, there are few non-surgical treatment options. They occur in 20−50% of women, especially in older women. Uterine fibroids are a major cause of morbidity in women of a reproductive age. In comparison to other non-malignant diseases, leiomyoma research is underfunded and there is currently no clinical method to distinguish a benign uterine leiomyoma from a malignant leiomyosarcoma prior to treatment. Mechanotransduction is a process of having an impact on cancer biology; where cells detect, interpret, and respond to mechanical signals further converting them to biochemical signals. This process is responsible for the activation of tumorigenic biochemical pathways. Extracellular matrix (ECM) accumulation is crucial for uterine leiomyoma. This study summarizes the available literature regarding ECM of uterine fibroids and the properties of cell and tissue stiffness that lead to signal transduction and contemporary understanding of mechanotransduction.


mechanotransduction; leiomyoma; cancer

Full Text:



Andrea Ciavattini, Jacopo Di Giuseppe, Piergiorgio Stortoni, Nina Montik, Stefano R Giannubilo, Pietro Litta, Md. Soriful Islam, Andrea L Tranquilli, Fernando M Reis, and Pasquapina Ciarmela. Uterine fibroids: Pathogenesis and interactions with endometrium and endomyometrial junction. Obstetrics and Gynecology International. 2013.

Darlene K Taylor, Kristine Holthouser, James H. Segars, Phyllis C Leppert. Recent scientific advances in leiomyoma (uterine fibroids) research facilitates better understanding and management. F1000Research. 2015; 183: 1−11p.

Aamir T Khan, Manjeet Shehmar, Janesh K Gupta. Uterine fibroids: current perspectives. International Journal of Women’s Health. 2014; 6: 95–114p.

LiKang Chin, Yuntao Xia, Dennis E Discher, Paul A Janmey. Mechanotransduction in cancer. Curr Opin Chem Eng. 2016; 11: 77–84p.

Ning Wang. Review of cellular mechanotransduction. J Phys D Appl Phys. 2017; 50 (23): 1−14p.

Rogers R, Norian J, Malik M et al. Mechanical homeostasis is altered in uterine leiomyoma. The American Journal of Obstetrics and Gynecology. 2008; 198 (4): 474.e1–474.e11p.

Norian JM, CM Owen, Taboas J, Casey Korecki, Rocky Tuan, Minnie Malik, William H Catherino, James H Segars. Characterization of tissue biomechanics and mechanical signaling in uterine leiomyoma. Matrix Biology. 2012; 31 (1): 57–65p.

Phyllis C Leppert, Friederike L Jayes, and James H Segars. The extracellular matrix contributes to mechanotransduction in uterine fibroids. Obstetrics and Gynecology International. 2014.

Jin Hao, Yueling Zhang, Rui Ye, Yingcheng Zheng, Zhihe Zhao, Juan Li. Mechanotransduction in cancer stem cells. Cell biology international. 2013; 37 (9): 888−891p.

Andrew W Holle, Jennifer L Young, Joachim P Spatz. In vitro cancer cell–ECM interactions inform in vivo cancer treatment. Advanced Drug Delivery Reviews. 2016; 97: 270–279p.

Md Soriful Islam, Andrea Ciavattini, Felice Petraglia, Mario Castellucci, Pasquapina Ciarmela. Extracellular matrix in uterine leiomyoma pathogenesis: a potential target for future therapeutics. Human Reproduction Update. 2018; 24 (1): 59–85p.

M Fairuz B Jamaluddin, Pravin Nahar, Pradeep S Tanwar. Proteomic characterization of the extracellular matrix of human uterine fibroids. Endocrinology. 2018; 159 (7): 2656–2669p.


  • There are currently no refbacks.